We see continued momentum even when we had personalized or compounded commercially available dosages of semaglutide on the platform." Medications like Wegovy are known as GLP-1 agonists, and many of these drugs were initially prescribed to manage Type 2 diabetes but have since gained popularity for helping patients manage weight
Its a wide spectrum of health not one size fits all, said Almandoz
The glucagon component, which directly stimulates hepatic fat oxidation, is thought to confer this advantage
Nevertheless, patients would continue to use it, above all if severe symptoms are present
Both retatrutide and tirzepatide are GLP-1 class medications developed by Eli Lilly, but they differ in receptor mechanism, FDA approval status, weight loss trial results, and availability
An analysis by financial firm Morgan Stanley Research put the number somewhat lower, but said its a large enough segment of the population to impact the food industry